Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,732 across all filing types
Latest filing 2023-07-12 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
112年07月法人說明會簡報 — 179520230712M003.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed presentation of the company's first quarter 2023 operational and financial results, including revenue growth, product approvals, market expansions, and R&D pipeline updates. It contains substantive financial data such as revenue, gross profit, net income, and EPS for the quarter, as well as detailed business and market information. The presence of forward-looking statements and detailed financial and operational metrics indicates this is a comprehensive quarterly report rather than a brief earnings release or a simple announcement. The document is about the first quarter (Q1) results, which is a period shorter than a full fiscal year, and includes actual financial statements and analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-07-12 Chinese
112年07月法人說明會簡報 — 179520230712E002.pdf
Investor Presentation Classification · 95% confidence The document is titled '2023 Q1 EARNINGS RESULTS Investor Presentation' and contains detailed financial results for the first quarter of 2023, including revenue, gross profit, net income, EPS, business highlights, portfolio development, and R&D pipeline updates. It is structured as a presentation with slides and charts, typical of investor presentations. The document is about 15,000 characters long, which is consistent with a detailed presentation rather than a brief announcement. There is no indication that this is a full quarterly report with comprehensive financial statements, but rather a presentation summarizing the quarter's financial results and business highlights for investors. Therefore, the document fits the category of an Investor Presentation (IP).
2023-07-12 Chinese
112年07月法人說明會簡報 — 179520230712M002.pdf
Investor Presentation Classification · 95% confidence The document is titled as a "2023 Q1 Operational Results Report" and is described as a presentation for an investor briefing (法人說明會簡報). It contains detailed financial results for the first quarter of 2023, including revenue, profit growth, EPS, product approvals, market expansions, and R&D pipeline updates. The content is typical of a quarterly earnings presentation with financial highlights and operational updates. The document length is substantial (15,000 characters), indicating it is not a brief announcement or a simple report publication notice. There is no indication that this is a full annual report (10-K) or an audit report. It is not a transcript of a call but rather a prepared presentation. Therefore, the best fitting category is "Investor Presentation (IP)" which covers detailed presentations for investors focusing on financials, strategy, and market position, especially quarterly operational results presentations.
2023-07-12 Chinese
112年07月法人說明會簡報 — 179520230712E001.pdf
Investor Presentation Classification · 95% confidence The document is titled '2023 Q1 EARNINGS RESULTS Investor Presentation' and contains detailed financial results for the first quarter of 2023, including revenue, gross profit, net income, EPS, business highlights, portfolio development, and R&D pipeline updates. It is structured as a presentation with slides and charts, typical of investor presentations. The document is about 15,000 characters long, indicating substantive content rather than a brief announcement. There is no indication that this is a full quarterly report filing (like a 10-Q or IR), but rather a presentation summarizing quarterly earnings and business updates for investors. Therefore, the document fits the category of an Investor Presentation (IP).
2023-07-12 Chinese
112年07月法人說明會簡報 — 179520230712M001.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed presentation of the company's operational and financial results for the first quarter of 2023. It includes forward-looking statements, quarterly financial highlights such as revenue, gross profit, net income, EPS, product approvals, market expansions, and R&D pipeline updates. The content is structured as a presentation with slides and charts, focusing on financial performance, business strategy, and market developments for the quarter. There is no indication that this is a full annual report, audit report, or regulatory filing. The document is not a transcript of a call, nor is it a voting result or a legal proceeding update. Given the detailed financial and operational data presented in a slide format, this fits the definition of an Interim / Quarterly Report (IR). The document length (15,000 characters) and substantive financial data support this classification rather than a brief announcement or a report publication notice. Q1 2023
2023-07-12 Chinese
112年07月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing of scheduled investor presentations (法人說明會) with dates, times, locations, and links to presentation materials. It does not contain actual financial statements or detailed financial analysis but rather information about upcoming or past investor presentations. The document length is short (1200 characters), and it serves as an announcement or schedule rather than a full report. Therefore, it fits the category of Investor Presentation (IP).
2023-07-12 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.